feed,title,long_url,short_url
Benzinga,Gilead Sciences Acquires Jounce Therapeutics Cancer Immunotherapy Program,https://benzinga.com/general/biotech/22/12/30212894/gilead-sciences-acquires-jounce-therapeutics-cancer-immunotherapy-program,https://da.gd/hKPGK
Benzinga,ATIF Inks IPO Consulting Agreement With Micro-Lodging Integrated Operator VESSEL,https://benzinga.com/news/22/12/30212832/atif-inks-ipo-consulting-agreement-with-micro-lodging-integrated-operator-vessel,https://da.gd/Y13wAC
